Recombinant Mouse Embigin homolog protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Mouse Embigin homolog protein is a Mouse Full Length protein, in the 34 to 330 aa range, expressed in Cell free, with >85%, suitable for SDS-PAGE.
View Alternative Names
Gp70, Emb, Embigin, Teratocarcinoma glycoprotein Gp-70
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Mouse Embigin homolog protein (AB289737)
SDS-PAGE analysis of ab289737
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Embigin is involved in the regulation of cell adhesion and proliferation. It is not generally part of a larger protein complex but acts as a facilitator of cellular interactions particularly during tissue morphogenesis and development. Embigin's role in promoting cell aggregation involves interaction with other cell surface proteins influencing cellular dynamics during development.
Pathways
Embigin plays a role in the integrin signaling pathway. It interacts with integrins which are transmembrane receptors involved in cell adhesion sending signals that regulate the cytoskeleton and the cell cycle. Another pathway related to Embigin's function is the PI3K/Akt signaling pathway. Through this pathway Embigin indirectly influences cellular survival and growth processes closely interacting with signaling proteins like PI3K.
Specifications
Form
Lyophilized
General info
Function
Plays a role in targeting the monocarboxylate transporters SLC16A1, SLC16A6 and SLC16A7 to the cell membrane (By similarity). Plays a role in the outgrowth of motoneurons and in the formation of neuromuscular junctions. Following muscle denervation, promotes nerve terminal sprouting and the formation of additional acetylcholine receptor clusters at synaptic sites without affecting terminal Schwann cell number or morphology. Delays the retraction of terminal sprouts following re-innervation of denervated endplates.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com